Provider review
bmiMD tirzepatide review
What bmiMD charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.
We tried to re-read bmiMD’s own pages on November 20, 2026. The page could not be read that day; the last record we hold, from 2026-09-17, put its lowest compounded tirzepatide figure at $179 a month (12-month plan on a promotional ladder). bmiMD is not scored in our November 20, 2026 computed ranking because bmimd.com refused our November 20, 2026 re-read. Sections below that show July 2026 records are kept as dated history.
What is distinctive about this programme
State-specific pricing, disclosed
bmiMD is one of only two providers in our dataset that publishes state-specific pricing: California and North Carolina residents pay $379.99 for compounded semaglutide against $289 elsewhere, a 31% difference.
State price variation generally reflects prescriber licensure costs or pharmacy shipping arrangements. Disclosing it is better practice than a single national figure that turns out not to apply at checkout, and it is worth knowing before you compare bmiMD against a national rate.
Pricing sits in the upper band
At $289 semaglutide and $399 tirzepatide, bmiMD is among the more expensive compounded programmes in our dataset. For context, brand Zepbound is $299 direct from LillyDirect and the approved oral orforglipron starts at $149 — both FDA-approved, both below bmiMD's compounded tirzepatide price.
The microdose figure is unusual
bmiMD's tirzepatide microdose is $349, and its semaglutide microdose is the same $289 as its standard programme. Across the rest of the market microdose programmes are the cheapest tier — $110 to $199. A microdose priced above most competitors' standard injectable, at a dose below any studied in the trials, is a combination worth asking about directly.
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Semaglutide injectable | $289 | Reported |
| Tirzepatide microdose | $349 | Reported |
| Tirzepatide injectable | $399 | Reported |
Where it holds up
- Publishes state-specific pricing rather than a national figure that changes at checkout
- All-inclusive structure with no separate membership
Where it does not
- Upper-band pricing at $289 semaglutide and $399 tirzepatide
- Compounded tirzepatide costs more than brand Zepbound direct from the manufacturer
- Microdose tirzepatide at $349 is above most competitors' standard injectable pricing
- California and North Carolina residents pay 31% more for semaglutide
- Figures are third-party reported and not yet captured by us
| Field | Position |
|---|---|
| Membership | Separate and required |
| Dose structure | Escalates with dose or not established |
| Lowest captured figure | $289/mo, month-to-month |
| Evidence status | Third-party reported, pending our own capture |
| Pharmacy named to us | No — provider-reported only |
Show this figure as a table
| Category | Points |
|---|---|
| Pricing transparency | 20 pts |
| Total annual cost | 20 pts |
| Clinical oversight | 15 pts |
| Pharmacy transparency | 15 pts |
| Support | 10 pts |
| Regulatory disclosure | 10 pts |
| Accessibility | 10 pts |
Pricing, all-in
Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| bmiMD | month_to_month | compounded injectable | — | $399 | — | $399 | Recurring | Reported | 2026-07-06 |
| bmiMD | month_to_month | compounded microdose | — | $349 | — | $349 | Recurring | Reported | 2026-07-06 |
| bmiMD | month_to_month | compounded injectable | — | $289 | — | $289 | Recurring | Reported | 2026-07-06 |
How this sits against the market
Show this figure as a table
| Program | All-in monthly | Read |
|---|---|---|
| Collective | $85.58 | Read 2026-10-15 |
| WellMedr | $89 | Read 2026-10-15 |
| Mondae | $114 | Read 2026-10-15 |
| NexLife | $115 | Read 2026-11-06 |
| Embody | $119 | Read 2026-10-15 |
| NextMeds | $119 | Read 2026-10-15 |
| SnagRx | $119 | Read 2026-10-15 |
| yourEra | $123 | Read 2026-10-15 |
| NewMeMeds | $125 | Older record, 2026-09-20 |
| CoreAge Rx | $129 | Read 2026-10-15 |
| Eden Health | $129 | Read 2026-10-15 |
| SkinnyRx | $129 | Older record, 2026-08-27 |
| GobyMeds | $133 | Read 2026-10-15 |
| Telos RX | $139 | Read 2026-10-15 |
| Sprout Health | $149 | Read 2026-10-15 |
| Strut Health | $149 | Read 2026-10-15 |
| He & She MD | $159 | Read 2026-10-15 |
| Bodybuilding Health+ | $174.67 | Read 2026-10-15 |
| bmiMD | $179 | Older record, 2026-09-17 |
| IVIM Health | $192 | Read 2026-10-15 |
| Alloy | $199 | Read 2026-10-15 |
| TelePep | $214 | Read 2026-10-15 |
| Yucca Health | $225 | Older record, 2026-09-12 |
| Found | $239 | Read 2026-10-15 |
| Pallas Health | $239 | Read 2026-10-15 |
| ShedRx | $239 | Read 2026-10-15 |
| MyDrHank | $240 | Older record, 2026-09-17 |
| Enhance.MD | $280 | Read 2026-10-15 |
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | — |
| Shipping | no | — |
| Higher-dose surcharge | no | — |
| Initial consultation | no | — |
| Required laboratory work | no | — |
| Cancellation or restocking terms | no | — |
A dash means no figure held. How we grade evidence.
This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.
Show this figure as a table
| Item | This provider | Category median |
|---|---|---|
| All-in monthly | not captured | not captured |
| Membership fee | not captured | not captured |
| Rubric score | not captured | not captured |
What is included, and what is not
Where it holds up
- nothing verified yet
Where it does not
- nothing verified yet
Where it operates
State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Clinical model
Pharmacy and fulfilment
Billing, cancellation and support
What changed
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How this compares to the category
Once enough providers are scored, this section reports where bmiMD sits against the median for each rubric category, not against a hand-picked competitor.
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | — | Not answered Pending |
| Clinical oversight and care continuity | 20 pts | — | Not answered Pending |
| State access and operational reliability | 10 pts | — | Not answered Pending |
| Cancellation, billing and support transparency | 10 pts | — | Not answered Pending |
A dash means no figure held. How we grade evidence.
Questions readers actually ask
Is bmiMD the cheapest option?
We will not answer that until the all-in figures are captured for the whole comparison set. A cheapest claim needs a defined comparison group, a stated program type and a capture date, or it is just an adjective.
Is this review sponsored?
No. Reviews here are not sponsored, and no provider can buy a score, a placement or a review. Tirzepatide Ranked is affiliate-supported; the disclosure page explains how.
Is compounded tirzepatide the same as Zepbound?
No. Compounded preparations are not FDA-approved products and there is no generic tirzepatide. Approval of the brand product does not extend to a compounded preparation.
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Ro Body Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Tirzepatide Ranked: Evidence, Prices, Providers & ToolsCore & Trust
- Tirzepatide Provider Comparison ToolTools
- Tirzepatide Price by DosePillar / Money
Related coverage
- Tirzepatide Provider Reviews
- Compounded tirzepatide price index
- What you pay at a maintenance dose
- Medicare GLP-1 Bridge: $50 a Month, and What the Fine Print Says
- Microdose Tirzepatide: The Evidence Gap
- Why Multi-Dose Vials Create Tirzepatide Dosing Errors
- The Oral GLP-1 Landscape in 2026
- Retatrutide Phase 3 Results: What Changed in July 2026
- Why Compounded GLP-1 Access Differs by State
Tirzepatide Ranked. “bmiMD Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/providers/bmimd/
Quote the capture date beside a figure, not the date you read this page. Why.
How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.